Blog

France’s Cellectis wins US patents for gene editing technology – Channel NewsAsia


Business Wire (press release)

France's Cellectis wins US patents for gene editing technology
Channel NewsAsia
"These inventions are based on the early work initiated by inventors at Cellectis when the CRISPR technology first came to light," the company said. CRISPR, an abbreviation of Clustered Regularly Interspaced Short Palindromic Repeats, forms the basis
Two Issued US Patents Granted to Cellectis for CRISPR Use in T-CellsBusiness Wire (press release)



all 3 news articles »

2018-02-13 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.